‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Is this email not displaying correctly? View it in your browser.
Image description

Last Reminder to Register the Free Webinar: Canine and Feline Parvovirus Infection: Diagnosis Challenge at Different Stages of the Diseases in Clinic

The free class “Continuous learning with Bioguard” theme for this month will be conducted by Yung-Tsun Lo, DVM, Ph.D. Dr. Lo is a veterinary expert at Bioguard Corporation.

Canine parvovirus (CPV) and Feline panleukopenia virus (FPV) are autonomous parvoviruses which infect dogs or cats, respectively. Both viruses causes acute gastrointestinal illness in kittens or puppies. Currently, the most common and most convenient method of testing for the presence of CPV or FPV is the fecal rapid test in clinic. Though the rapid test is fairly accurate, it can occasionally produce false positive or false negative results. Therefore, veterinarians may pose a question, why do CPV or FPV rapid tests show negative results in severe cases? We will discuss the issue further in this lecture.

Image description

In this lecture, you will learn all about cause, symptoms, treatment and most of all diagnosis of parvovirus in dogs and cats. Early detection and prompt treatment are critical on the approach in dealing with parvovirus infection. So we welcome you to join and participate in this wonderful free class.

Register For the Free Class

Date: Feb 23rd, 2022

Time: 7:00 pm - 8:00 pm (GMT+7)

Presenters: Dr. Yung-Tsun Lo

Cost: FREE

Bioguard is looking forward to seeing you at this event. Happy Learning!

Follow our Facebook and LinkedIn

Facebook icon
Twitter icon
Instagram icon
Facebook icon

About Bioguard Corporation

The Bioguard is a company focusing on animal

disease diagnostic services and products.
Our animal health diagnostic center is

the first and only ISO/ IEC 17025 accredited animal disease testing laboratory

in Taiwan and China.

Copyright © Bioguard Corp., All rights reserved.

Our mailing address is: [email protected]

If you want to unsubscribe, click here.